Wednesday 30 August 2017

Parkinsons Disease 2018

About Conference


ALLIED ACADEMIES every year hosts interdisciplinary international conferences worldwide on cutting-edge basic and applied research in life sciences, Pharma, medicine, healthcare and nursing delivered by the best talents in industry and academia. Our conferences are oriented to drive the scientific community at large, facilitating access to the newest technical and scientific achievements and to shape future research directions through the publication of applied and theoretical research findings of the highest quality.

We take the honor to welcome all the Healthcare professionals, company’s, research centers and laboratories belonging to the field of Neuroscience and Neurodegenerative disorders towards the 10th World Congress on Parkinson's Disease and Movement Disorders during May 25-26, 2018 at New York, USA.
Allied Academies is pleased to welcome all the Deans, Heads, Practitioners, researchers, scientists, professors and young researchers who are contributing towards the field of Neurology and Neuroscience for "10th World Congress onParkinson's Disease and Movement Disorders during May 25-26, 2018 at New York, USA". The theme of Parkinsons Disease 2018 conference is based on "Leading Innovation and Remedial Insight of Parkinson’s Disease". The Conference will serve as an informative and unique podium providing researchers and the healthcare concerns, to share, discuss, learn exchange and initiate the betterment In the Neurological World.
Parkinson’s disease is one of the most common neurodegenerative disorders. It is estimated to affect up to 160 per 100,000 of the general population with an annual incidence of 15–20 per 100,000. Many population studies have shown the rising prevalence with age (up to 2% of the population aged 80 and over). Around 1 in 7 cases are diagnosed below the age of 60 years. The costs of treatment have been estimated at between £560,000 and £1.6 million per 100,000 of the population.
In USA a 3-year prospective study of the economic cost of PD was performed in 2006. The average annual cost per patient was estimated at $12,091, out of which 55.9% accounted for direct costs. Drugs took up the major share of direct costs, $5,763 per year. Indirect costs accounted for $4,851 per patient per year. Within this, 76% of the costs were related to nursing care and the loss of productivity.

Conference Highlights